| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K16147474 |
| PharmacoGx | BRD-K16147474 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPBG | CTRPv2 | pan-cancer | AAC | -0.078 | 0.08 |
| mRNA | UBE2L6 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.08 |
| mRNA | TMEM130 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.08 |
| mRNA | PSMB11 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | AC104073.1 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | BRE | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |
| mRNA | FOXO3 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.08 |
| mRNA | CYP7B1 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.08 |
| mRNA | CACNA1D | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | ZNF503 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.08 |
